Northern Ireland (Executive Formation) Bill

Is my right hon. Friend aware that a review into the medicine Roaccutane, which is under an EU licence, has not been published because of issues with the Northern Ireland protocol? Since then, there have been 81 adverse health effects, including one suicide. It has been specifically said that that delay is due to the Northern Ireland protocol and the issues with the licensing arrangements. Roaccutane is licensed across the EU, and unfortunately the publication of the report has been held up, with 81 adverse health events as a result.